News
After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...
The Food and Drug ... pharmacy benefit manager, said the drug from Gilead Sciences “is priced as if it were treating an extremely rare condition,” although an estimated 3 million people in the US have ...
5d
KFF Health News on MSNKFF Health News' 'What the Health?': RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’tHealth and Human Services Secretary Robert F. Kennedy Jr. this week did something he had promised not to do: He fired every ...
The specialty drug pipeline is robust with several new medications anticipated to gain approval in the coming years. Healthcare leaders need to be poised to have a deep understanding of the clinical ...
My company, CSX Railroad, changed from Express Scripts to Optum RX. Optum said we would not have to do anything in the changeover, but it has been a mess for all employees. Not only did we lose ...
The UnitedHealth Group division is taking Johnson & Johnson's Stelara — one of the most popular, best-known and most expensive "biologic" anti-inflammatory drugs — off the standard formulary for many ...
It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA ...
Approximately half of all respondents reported that their facility uses tall man lettering for similar drug names that appear on pharmacy computer ... included the ISMP list of name pairs with ...
As a result, he continued, "the most advanced drugs are too costly to help as many people as they could. In emerging fields such as gene and cell therapy, better manufacturing technology is ...
Among the many allegations contained within the papers are claims that Diddy filmed fellow A-list celebrities taking drugs and having sex with prostitutes. In many cases, the name of the ...
An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results